205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-4.54%
Revenue decline while MRVL shows 13.29% growth. Joel Greenblatt would examine competitive position erosion.
-2.55%
Cost reduction while MRVL shows 6.70% growth. Joel Greenblatt would examine competitive advantage.
-7.90%
Gross profit decline while MRVL shows 18.86% growth. Joel Greenblatt would examine competitive position.
-3.53%
Margin decline while MRVL shows 4.92% expansion. Joel Greenblatt would examine competitive position.
-0.72%
R&D reduction while MRVL shows 14.00% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.31%
Operating expenses reduction while MRVL shows 1.68% growth. Joel Greenblatt would examine advantage.
-2.81%
Total costs reduction while MRVL shows 2.62% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
1.19%
D&A growth while MRVL reduces D&A. John Neff would investigate differences.
-6.99%
EBITDA decline while MRVL shows 61.57% growth. Joel Greenblatt would examine position.
-2.57%
EBITDA margin decline while MRVL shows 42.61% growth. Joel Greenblatt would examine position.
-38.53%
Operating income decline while MRVL shows 4.72% growth. Joel Greenblatt would examine position.
-35.61%
Operating margin decline while MRVL shows 15.89% growth. Joel Greenblatt would examine position.
-1574.42%
Other expenses reduction while MRVL shows 51.40% growth. Joel Greenblatt would examine advantage.
-473.03%
Pre-tax income decline while MRVL shows 5.69% growth. Joel Greenblatt would examine position.
-490.76%
Pre-tax margin decline while MRVL shows 16.76% growth. Joel Greenblatt would examine position.
161.11%
Tax expense growth 1.25-1.5x MRVL's 114.83%. Martin Whitman would scrutinize strategy.
-413.30%
Net income decline while MRVL shows 5.00% growth. Joel Greenblatt would examine position.
-428.19%
Net margin decline while MRVL shows 16.14% growth. Joel Greenblatt would examine position.
-427.27%
EPS decline while MRVL shows 4.35% growth. Joel Greenblatt would examine position.
-427.27%
Diluted EPS decline while MRVL shows 4.35% growth. Joel Greenblatt would examine position.
-4.63%
Both companies reducing share counts. Martin Whitman would check patterns.
-4.63%
Both companies reducing diluted shares. Martin Whitman would check patterns.